Loading organizations...
Fresenius Medical Care Ventures is the corporate venture capital arm of Fresenius Medical Care that invests in early-stage healthcare startups focused on kidney care and renal technologies, operating out of Waltham, Massachusetts, and Bad Homburg, Germany. The firm leverages the extensive global infrastructure of its parent organization, which employs over 120,000 people, operates approximately 4,100 dialysis clinics across more than 65 countries, and treats around 345,000 patients annually. Backed entirely by its parent company, the venture division targets strategic growth opportunities in chronic kidney disease management and related health tech sectors. The fund operates under the broader corporate leadership of executives like former CEO Rice Powell, while supporting a network of healthcare innovators. The parent organization, tracing its historical roots back to pharmacist Dr. Eduard Fresenius in 1912, was officially established in 1996.
Key people at Fresenius Medical Care Ventures.
Key people at Fresenius Medical Care Ventures.
Fresenius Medical Care Ventures has 4 tracked investments across 3 companies. The latest tracked deal is $22.0M Series C in Memo Therapeutics in May 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2024 | Memo Therapeutics | $22.0M Series C | — | Kurma Partners, Adjuvant Capital, GF Group, Pureos Bioventures, Redalpine, Schroders Capital, Swisscanto Invest, Verve Ventures, Vesalius Biocapital, Thomas Harth |
| Nov 1, 2023 | Memo Therapeutics | $28.0M Series C | Veronica Gambillara Fonck | Adjuvant Capital, Kurma Partners, Pureos Bioventures, GF Group, Redalpine, Schroders Capital, Swisscanto Invest, Verve Ventures, Vesalius Biocapital |
| Apr 25, 2018 | Corvidia | $60.0M Series B | Karim Helmy | Andera Partners, Apple Tree Partners, Cormorant Asset Management, HBM Healthcare Investments, MedImmune, Sofinnova Partners |
| Nov 16, 2017 | Modulim | $4.1M Grant / Series A | Grey SKY Venture Partners | Mitsuharu Miwa, Mitsubishi UFJ Capital, National Institute OF Arthritis And Musculoskeletal And Skin Diseases |